Mixed orl1/mu-agonists for the treatment of pain

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/407 (2006.01) A61K 31/438 (2006.01) A61P 25/04 (2006.01)

Patent

CA 2664702

The invention relates to the use of compounds having an affinity for the µ opioid receptor of at least 100 nM (Ki human value) and an affinity for the ORL-1 receptor for producing a medicament for treating pain, the ratio between the ORL1/µ affinities defined as 1/[Ki(ORL1)/Ki(µ)] being between 0.1 and 30.

L'invention concerne l'utilisation de composés qui présentent une affinité pour le récepteur opioïde µ d'au moins 100 nM (valeur Ki chez l'homme) et une affinité pour le récepteur ORL-1 pour produire un médicament contre la douleur, le rapport entre les affinités ORL1/µ représenté par 1/[Ki(ORL1)/Ki(µ)] étant compris entre 0,1 et 30.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mixed orl1/mu-agonists for the treatment of pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mixed orl1/mu-agonists for the treatment of pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mixed orl1/mu-agonists for the treatment of pain will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2023365

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.